Matošević, A.; Radman Kastelic, A.; Mikelić, A.; Zandona, A.; Katalinić, M.; Primožič, I.; Bosak, A.; Hrenar, T.
Quinuclidine-Based Carbamates as Potential CNS Active Compounds. Pharmaceutics 2021, 13, 420.
https://doi.org/10.3390/pharmaceutics13030420
AMA Style
Matošević A, Radman Kastelic A, Mikelić A, Zandona A, Katalinić M, Primožič I, Bosak A, Hrenar T.
Quinuclidine-Based Carbamates as Potential CNS Active Compounds. Pharmaceutics. 2021; 13(3):420.
https://doi.org/10.3390/pharmaceutics13030420
Chicago/Turabian Style
Matošević, Ana, Andreja Radman Kastelic, Ana Mikelić, Antonio Zandona, Maja Katalinić, Ines Primožič, Anita Bosak, and Tomica Hrenar.
2021. "Quinuclidine-Based Carbamates as Potential CNS Active Compounds" Pharmaceutics 13, no. 3: 420.
https://doi.org/10.3390/pharmaceutics13030420
APA Style
Matošević, A., Radman Kastelic, A., Mikelić, A., Zandona, A., Katalinić, M., Primožič, I., Bosak, A., & Hrenar, T.
(2021). Quinuclidine-Based Carbamates as Potential CNS Active Compounds. Pharmaceutics, 13(3), 420.
https://doi.org/10.3390/pharmaceutics13030420